CompletedNot Applicable

Visualization of the Papilla Through Use of the NuView Device in Patients With FAP

United States3 participantsStarted 2023-01-27

Plain-language summary

The goal of this observational study is to test the NuView device in participants with familial adenomatous polyposis (FAP). The main question it aims to answer is: * can the papilla be visualized using a forward-facing endoscope outfitted with the NuView device. Participants will undergo standard of care esophagogastroduodenoscopy with an additional endoscopic exam using NuView device, for which participant have given prior consent.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female, 18 to 70 years of age. * Able to provide written informed consent. * Have FAP Exclusion Criteria: * Females who are pregnant. As part of routine pre-operative care, all females of childbearing potential will undergo either urine or blood pregnancy testing. * Cancer positive subjects or any patients currently undergoing any treatment or therapy to treat, cure, or mitigate cancer. * Patients who do not meet inclusion criteria * Patients who are unable or unwilling to provide informed consent

What they're measuring

Visualization of papilla

Timeframe: 1 day

Trial details

NCT IDNCT05657145

SponsorVanderbilt University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-30

View on ClinicalTrials.gov More Familial Adenomatous Polyposis trials